Corbus Pharmaceuticals (CRBP) has an average rating of buy and mean price target of $36.30, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Price: $8.64, Change: $+0.33, Percent Change: +3.97%